BUD - Anheuser-Busch InBev SA/NV
NYSE
->
Consumer Defensive
->
Beverages—Brewers
Leuven,
Belgium
Type: Equity
BUD price evolution
BUD
| (in millions $) | 30 Oct 2024 | 30 Jul 2024 | 1 May 2024 | 31 Jan 2024 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $4636 | $6131 | ||
| Short term investments | ||||
| Net receivables | $7316 | $6846 | ||
| Inventory | $5567 | $5583 | ||
| Total current assets | $21026 | $23367 | ||
| Long term investments | ||||
| Property, plant & equipment | $25086 | $26818 | ||
| Goodwill & intangible assets | ||||
| Total noncurrent assets | ||||
| Total investments | ||||
| Total assets | $210720 | $219340 | ||
| Current liabilities | ||||
| Accounts payable | $21708 | $17729 | ||
| Deferred revenue | ||||
| Short long term debt | ||||
| Total current liabilities | $30566 | $37156 | ||
| Long term debt | $75944 | $74163 | ||
| Total noncurrent liabilities | ||||
| Total debt | ||||
| Total liabilities | $132204 | $137492 | ||
| Shareholders' equity | ||||
| Retained earnings | $98705 | $97111 | ||
| Other shareholder equity | -$35387 | -$31154 | ||
| Total shareholder equity | ||||
| (in millions $) | 31 Jan 2024 | 31 Jan 2023 | 18 Mar 2022 | 30 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $6131 | $5288 | $12471 | $15252 |
| Short term investments | $505 | $331 | $621 | $396 |
| Net receivables | $6372 | $5733 | $5427 | $5134 |
| Inventory | $5583 | $6612 | $5399 | $4482 |
| Total current assets | $23367 | $23186 | $23948 | $26519 |
| Long term investments | $195973 | $189757 | $193678 | $6280 |
| Property, plant & equipment | $26818 | $26671 | $26678 | $26419 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | $199890 | |||
| Total investments | ||||
| Total assets | $219340 | $212943 | $217626 | $226410 |
| Current liabilities | ||||
| Accounts payable | $17729 | $18589 | $25434 | $15898 |
| Deferred revenue | ||||
| Short long term debt | $4004 | $83 | $1461 | $1162 |
| Total current liabilities | $37156 | $34383 | $34184 | $32352 |
| Long term debt | $74163 | $78880 | $87369 | $93641 |
| Total noncurrent liabilities | $115708 | |||
| Total debt | $98564 | |||
| Total liabilities | $137492 | $139545 | $148959 | $148059 |
| Shareholders' equity | ||||
| Retained earnings | $97111 | $93300 | $33882 | $30870 |
| Other shareholder equity | -$31154 | -$35552 | $19425 | $22709 |
| Total shareholder equity | $81847 | $73397 | $68669 | $68024 |
| (in millions $) | 30 Oct 2024 | 30 Jul 2024 | 1 May 2024 | 31 Jan 2024 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $14547 | $14473 | ||
| Cost of revenue | ||||
| Gross Profit | $7894 | $7794 | ||
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | ||||
| Total operating expenses | $4252 | $4303 | ||
| Operating income | ||||
| Income from continuing operations | ||||
| EBIT | ||||
| Income tax expense | $794 | $376 | ||
| Interest expense | -$796 | -$358 | ||
| Net income | ||||
| Net income | $1091 | $1891 | ||
| Income (for common shares) | ||||
| (in millions $) | 31 Jan 2024 | 17 Mar 2023 | 31 Jan 2022 | 30 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $59380 | $57786 | $46881 | |
| Cost of revenue | $26305 | $19634 | ||
| Gross Profit | $31984 | $31481 | $27247 | |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $17555 | $15451 | ||
| Total operating expenses | $17511 | $43860 | $34777 | |
| Operating income | $13926 | $12104 | ||
| Income from continuing operations | ||||
| EBIT | $14783 | $12104 | ||
| Income tax expense | $2234 | $1927 | $1932 | |
| Interest expense | -$4150 | -$4120 | ||
| Net income | ||||
| Net income | $5341 | $5968 | $1405 | |
| Income (for common shares) | $5968 | $1405 | ||
| (in millions $) | 30 Jul 2024 | 31 Jan 2024 | 30 Jul 2023 | 31 Jan 2023 |
|---|---|---|---|---|
| Net income | ||||
| Operating activities | ||||
| Depreciation | ||||
| Business acquisitions & disposals | ||||
| Stock-based compensation | ||||
| Total cash flows from operations | ||||
| Investing activities | ||||
| Capital expenditures | ||||
| Investments | ||||
| Total cash flows from investing | -$1732 | -$4354 | -$2061 | -$4620 |
| Financing activities | ||||
| Dividends paid | -$2142 | -$3013 | -$1923 | -$2442 |
| Sale and purchase of stock | ||||
| Net borrowings | ||||
| Total cash flows from financing | -$3313 | -$8596 | -$2823 | -$10620 |
| Effect of exchange rate | -$463 | $109 | $191 | -$211 |
| Change in cash and equivalents | -$2940 | $424 | -$3096 | -$2153 |
| (in millions $) | 31 Jan 2024 | 17 Mar 2023 | 18 Mar 2022 | 30 Dec 2020 |
|---|---|---|---|---|
| Net income | $5968 | $4669 | $1405 | |
| Operating activities | ||||
| Depreciation | $5078 | $5052 | $4155 | |
| Business acquisitions & disposals | ||||
| Stock-based compensation | ||||
| Total cash flows from operations | $13298 | $14800 | $10891 | |
| Investing activities | ||||
| Capital expenditures | -$5160 | -$5640 | -$3781 | |
| Investments | ||||
| Total cash flows from investing | -$4354 | -$4620 | -$5877 | $6336 |
| Financing activities | ||||
| Dividends paid | -$3013 | -$1800 | ||
| Sale and purchase of stock | ||||
| Net borrowings | $68562 | $75738 | -$8755 | |
| Total cash flows from financing | -$8596 | -$10620 | -$11598 | -$8475 |
| Effect of exchange rate | $109 | -$674 | ||
| Change in cash and equivalents | $424 | -$2401 | -$3177 | $8078 |
News
Fundamentals
| Market cap | N/A |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | N/A |
| Revenue | N/A |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | N/A |
| Revenue Q/Q | N/A |
| Revenue Y/Y | N/A |
| P/E ratio | N/A |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | N/A |
|---|---|
| ROA | N/A |
| ROE | N/A |
| Debt/Equity | 1.68 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | N/A |
| Quick ratio | N/A |